The key data points of the above infographic from Decision Resources Group include:
• >280 biosimilars in the pipeline
• 17 biosimilar products approved in EEA (see the Table to the right)
• >20% annual increase in biosimilars in clinical trials
• 32 biologic molecules targeted by biosimilar developers
To download your own copy, click here.